Can we help?

call us on +44 (0)131 4456077
or email

Investor relations

Bespoke solutions from clinical trial to launch

Investor relations

Financial reports

2011

Angel Biotechnology Holdings Plc's 2011 interims results for the six month period ended 30 June 2011 (53KB).

2010

Angel Biotechnology Holdings PLC Annual Report & Accounts 2010 (236KB).
Angel Biotechnology Holdings Plc's 2010 interims results for the six month period ended 30 June 2010 (40KB).

2009

Angel Biotechnology Holdings Plc's Annual Report & Accounts 2009 (532KB).
Angel Biotechnology Holdings Plc's 2009 interims results for the six month period ended 30 June 2009 (38KB).

2008

Angel Biotechnology Holdings Plc's Annual Report & Accounts 2008 (348KB).
Angel Biotechnology Holdings Plc's 2008 interims results for the six month period ended 30 June 2008 (35KB).

2007

Angel Biotechnology Holdings Plc's Annual Report & Accounts 2007 (347KB).
Angel Biotechnology Holdings Plc's 2007 interims results for the six month period ended 30 June 2007 (45KB).

2006

Angel Biotechnology Holdings Plc's Annual Report & Accounts 2006 (288KB).
Angel Biotechnology Holdings Plc's 2006 interims results for the six month period ended 30 June 2006 (151KB).

2005

Angel Biotechnology Holdings Plc's Annual Report & Accounts 2005(328KB).

Contact us

for investor relations queries:
Lorna Peers
Finance Director and Company Secretary
Tel:+44 (0)131 4456077
enquiries@angelbio.com

Our services

Along with the successful production of recombinants, Angel provides development and process scale-up strategies

Our services